Decoy Therapeutics Inc. (DCOY) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Decoy Therapeutics Inc. (DCOY) closed at USD 1.17 on 2026-10-14, a change of -97.4 % over the past year, with a market capitalization of USD 2.93M.

Decoy Therapeutics Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Decoy Therapeutics Inc. key figures

Previous close

USD 1.17 (2026-10-14)

1-year change

-97.4 %

Market cap

USD 2.93M

Enterprise value

USD -7.48M

P/E ratio (trailing)

0.10

P/E ratio (forward)

-0.15

EPS (trailing)

12.24

EPS (forward)

-8.28

PEG ratio

n/a

Price to book

0.15

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.02

Employees

11

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Decoy Therapeutics Inc.

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company's IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs. It focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Houston, Texas.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Decoy Therapeutics Inc. and compare it with other stocks.